OBJECTIVE: To evaluate a manual method (Cytosphere) for quantifying CD4+ T-cell numbers. DESIGN: Cross-sectional study of HIV-1-seronegative and HIV-1-seropositive individuals evaluated for absolute CD4 counts by both standardized flow cytometric measurements and manual Cytosphere technology using a hemacytometer. SETTING: University research hospitals in both the United States and Africa. PATIENTS, PARTICIPANTS: Blood specimens from 382 patients were evaluated. These were broken down into 294 samples obtained from HIV-1-seropositive patients and 88 samples obtained from HIV-1-seronegative patients. INTERVENTIONS: None. OUTCOME MEASURED: Absolute CD4 cell number. RESULTS: Evaluation of samples obtained from HIV-1 patients in both the United States and Africa demonstrated an overall correlation of the Cytosphere assay with flow cytometry of 0.912 (95% confidence interval, 0.895-0.928; P < 0.001). When samples were stratified based on CD4+ T-cell counts determined by flow cytometry, the Cytosphere assay had a 96% predictive value for correctly identifying individuals with CD4 T-cell counts > 200 x 10(6)/l and a 92% predictive value for correctly identifying individuals with CD4 T-cell counts < 200 x 10(6)/l. CONCLUSIONS: This assay appears to have the potential for the quantitation of CD4 cells in the limited laboratory facilities in developing countries and to have a strong correlation with standard flow cytometric technology.
OBJECTIVE: To evaluate a manual method (Cytosphere) for quantifying CD4+ T-cell numbers. DESIGN: Cross-sectional study of HIV-1-seronegative and HIV-1-seropositive individuals evaluated for absolute CD4 counts by both standardized flow cytometric measurements and manual Cytosphere technology using a hemacytometer. SETTING: University research hospitals in both the United States and Africa. PATIENTS, PARTICIPANTS: Blood specimens from 382 patients were evaluated. These were broken down into 294 samples obtained from HIV-1-seropositivepatients and 88 samples obtained from HIV-1-seronegative patients. INTERVENTIONS: None. OUTCOME MEASURED: Absolute CD4 cell number. RESULTS: Evaluation of samples obtained from HIV-1patients in both the United States and Africa demonstrated an overall correlation of the Cytosphere assay with flow cytometry of 0.912 (95% confidence interval, 0.895-0.928; P < 0.001). When samples were stratified based on CD4+ T-cell counts determined by flow cytometry, the Cytosphere assay had a 96% predictive value for correctly identifying individuals with CD4 T-cell counts > 200 x 10(6)/l and a 92% predictive value for correctly identifying individuals with CD4 T-cell counts < 200 x 10(6)/l. CONCLUSIONS: This assay appears to have the potential for the quantitation of CD4 cells in the limited laboratory facilities in developing countries and to have a strong correlation with standard flow cytometric technology.
Entities:
Keywords:
Acquired Immunodeficiency Syndrome; Americas; Antibodies; Biology; Comparative Studies; Cross Sectional Analysis; Cytology; Developed Countries; Developing Countries; Diseases; Examinations And Diagnoses; Hematologic Tests; Hiv Infections; Immunity; Immunologic Factors; Laboratory Examinations And Diagnoses; Laboratory Procedures; Methodological Studies; North America; Northern America; Physiology; Research Methodology; Studies; United States; Viral Diseases
Authors: J B Jackson; E M Piwowar; J Parsons; P Kataaha; G Bihibwa; J Onecan; S Kabengera; S D Kennedy; A Butcher Journal: J Clin Microbiol Date: 1997-04 Impact factor: 5.948
Authors: Cathy Logan; Monique Givens; Jeffrey T Ives; Marie Delaney; Michael J Lochhead; Robert T Schooley; Constance A Benson Journal: J Immunol Methods Date: 2012-10-11 Impact factor: 2.303
Authors: J Gupta; D Chattopadhaya; D P Bhadoria; M A Qadar Pasha; V K Gupta; M Kumar; R Dabur; V Yadav; G L Sharma Journal: Clin Exp Immunol Date: 2007-06-12 Impact factor: 4.330
Authors: Fred Lutwama; Ronnie Serwadda; Harriet Mayanja-Kizza; Hasan M Shihab; Allan Ronald; Moses R Kamya; David Thomas; Elizabeth Johnson; Thomas C Quinn; Richard D Moore; Lisa A Spacek Journal: J Acquir Immune Defic Syndr Date: 2008-07-01 Impact factor: 3.731